CardiacSense For Profit

CardiacSense is a company that offers a medical-grade watch for continuous detection of atrial fibrillation, hypertension, and other heart-related issues. The watch provides constant monitoring and accurate results with 99% sensitivity and 99% specificity in distinguishing atrial fibrillation (AF) from sinus rhythm. The company has received regulatory approval from the Israeli Ministry of Health, FDA clearance, and CE Mark for marketing and sales of the CardiacSense medical watch in the European Union. They have also signed a $32.4m medical watch Indian deal. Contact_info: info@cardiacsense.com, support@cardiacsense.com.

Headquarters: Caesarea, Hefa, Israel
Last Funding Type: Venture - Series Unknown
Investors Number: 1
Last Funding Date: 2019-03-31
Employee Number: 11-50
Founded Date: 2009-12-29
Technology: Biomarker panels
Estimated Revenue: <$1M
Investor Type: For Profit
Industry: Clinical Data Management
Funding Status: Early Stage Venture